tm
Seeing Is Believing
tm
Seeing Is Believing
AVIR is currently covered by 2 analysts with an average price target of $5.63. This is a potential upside of $1.89 (50.53%) from yesterday's end of day stock price of $3.74.
Atea Pharmaceuticals 's activity chart (see below) currently has 19 price targets and 14 ratings on display. The stock rating distribution of AVIR is 75% SELL and 25% HOLD.
Analysts average stock forecasts to be materialized ratio is 63.33% with an average time for these price targets to be met of 51.5 days.
Highest price target for AVIR is $9, Lowest price target is $3, average price target is $5.63.
Most recent stock forecast was given by ERIC JOSEPH from JPMORGAN on 10-Aug-2023. First documented stock forecast 24-Nov-2020.
Currently out of the existing stock ratings of AVIR, 3 are a SELL (75%), 1 are a HOLD (25%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
8
8 months 9 days ago
3/5 (60%)
$4.32 (117.39%)
55
Sell
4
$0.24 (6.38%)
7
1 years 2 months 26 days ago
6/9 (66.67%)
$-0.55 (-12.09%)
48
What is AVIR (Atea Pharmaceuticals ) average time for price targets to be met?
Which analyst has the current highest performing score on AVIR (Atea Pharmaceuticals ) with a proven track record?
Which analyst has the current lower performing score on AVIR (Atea Pharmaceuticals ) with a proven track record?
Which analyst has the most public recommendations on AVIR (Atea Pharmaceuticals )?
Which analyst is the currently most bullish on AVIR (Atea Pharmaceuticals )?
Which analyst is the currently most reserved on AVIR (Atea Pharmaceuticals )?
